Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Donix, Lukas"'
Autor:
Donix, Lukas, Erb, Holger H. H., Peitzsch, Claudia, Dubrovska, Anna, Pfeifer, Manuel, Thomas, Christian, Fuessel, Susanne, Erdmann, Kati
Purpose: Platinum chemotherapy can be considered to treat metastatic castration-resistant prostate cancer (mCRPC) with features of neuroendocrine differentiation. However, platinum compounds are generally only applied after the failure of multiple pr
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A89126
https://tud.qucosa.de/api/qucosa%3A89126/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A89126/attachment/ATT-0/
Autor:
Donix, Lukas
Die Dissertationsarbeit untersucht genetische Varianten in Zellkulturmodellen des metastatischen und kastrationsresistenten Prostatakarzinoms. Außerdem werden Mechanismen der Chemoresistenz, insbesondere der Resistenz gegen Cisplatin und Docetaxel i
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A85774
https://tud.qucosa.de/api/qucosa%3A85774/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A85774/attachment/ATT-0/
Autor:
Linke, Dinah1,2,3 (AUTHOR), Donix, Lukas1,2,3 (AUTHOR), Peitzsch, Claudia2,3,4,5 (AUTHOR), Erb, Holger H. H.1,3,6 (AUTHOR), Dubrovska, Anna2,3,4,6,7 (AUTHOR), Pfeifer, Manuel8 (AUTHOR), Thomas, Christian1,2,3 (AUTHOR), Fuessel, Susanne1,3,6 (AUTHOR) susanne.fuessel@ukdd.de, Erdmann, Kati1,2,3,6 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Jan2023, Vol. 24 Issue 1, p666. 23p.
Autor:
Erb, Holger H. H., Bodenbender, Julia, Handle, Florian, Diehl, Tamara, Donix, Lukas, Tsaur, Igor, Gleave, Martin, Haferkamp, Axel, Huber, Johannes, Fuessel, Susanne, Juengel, Eva, Culig, Zoran, Thomas, Christian
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237248 (2020)
PLoS ONE
PLoS ONE
Despite enzalutamide's efficacy in delaying the progression of metastatic castration-resistant prostate cancer (CRPC), resistance to this anti-androgen inevitably occurs. Several studies have revealed that the signal transducer and activator of trans
Autor:
Erb, Holger Hans Hermann, Ebert, Marlies, Kuhn, Ronja, Donix, Lukas, Haferkamp, Axel, Seed, Robert Ian, Jüngel, Eva
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 10, p e0224085 (2019)
PLoS ONE, Vol 14, Iss 10, p e0224085 (2019)
Urothelial cancer (UC) is one of the most common cancers in Europe and is also one of the costliest to treat. When first line therapies show initial success, around 50% of cancers relapse and proceed to metastasis. In this study we assessed the Prote
Autor:
Wasielewska, Joanna M., Grönnert, Lisa, Rund, Nicole, Donix, Lukas, Rust, Ruslan, Sykes, Alexander M., Hoppe, Anja, Roers, Axel, Kempermann, Gerd, Walker, Tara L.
Publikováno v:
Scientific Reports; 12/19/2017, Vol. 7 Issue 1, p1-13, 13p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wasielewska, Joanna M., Grönnert, Lisa, Rund, Nicole, Donix, Lukas, Rust, Ruslan, Sykes, Alexander M., Hoppe, Anja, Roers, Axel, Kempermann, Gerd, Walker, Tara L.
Publikováno v:
Scientific Reports; 11/9/2020, Vol. 10 Issue 1, pN.PAG-N.PAG, 1p
Autor:
Linke D; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Donix L; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Peitzsch C; National Center for Tumor Diseases (NCT), Partner Site Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01309 Dresden, Germany.; Center for Regenerative Therapies Dresden (CRTD), 01307 Dresden, Germany., Erb HHH; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany., Dubrovska A; National Center for Tumor Diseases (NCT), Partner Site Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01309 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01309 Dresden, Germany., Pfeifer M; Institute of Legal Medicine, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Thomas C; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Fuessel S; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany., Erdmann K; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Dec 30; Vol. 24 (1). Date of Electronic Publication: 2022 Dec 30.
Autor:
Donix L; Department of Urology, Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Erb HHH; Department of Urology, Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany., Peitzsch C; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; National Center for Radiation Research in Oncology (OncoRay), Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Dubrovska A; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; National Center for Radiation Research in Oncology (OncoRay), Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany., Pfeifer M; Institute of Legal Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Thomas C; Department of Urology, Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Fuessel S; Department of Urology, Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.; National Center for Radiation Research in Oncology (OncoRay), Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Erdmann K; Department of Urology, Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany. kati.erdmann@uniklinikum-dresden.de.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. kati.erdmann@uniklinikum-dresden.de.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany. kati.erdmann@uniklinikum-dresden.de.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2022 Jun; Vol. 148 (6), pp. 1313-1324. Date of Electronic Publication: 2022 Jan 12.